Schiff bases in medicinal chemistry: a patent review (2010-2015)

References

• Dutta B, Bag P, Adhikary B, et al. Efficient proton-templated synthesis of 18-to 38-membered tetraimino (amino) diphenol macrocyclic ligands: structural features and spectroscopic properties. J Org Chem. 2004;69(16):5419–5427.
   PubMed Web of Science ®Google Scholar
• Di Bernardo P, Zanonato P, Tamburini S, et al. Complexation behaviour and stability of Schiff bases in aqueous solution. The case of an acyclic diimino (amino) diphenol and its reduced triamine derivative. Dalton Trans. 2006;(39):4711–4721. Available from: http://pubs.rsc.org/en/Content/ArticleLanding/2006/DT/b604211b#!divAbstract
   PubMed Web of Science ®Google Scholar
• Kirdant A, Shelke V, Shankarwar S, et al. Kinetic study of hydrolysis of N-salicylidene-m-methyl aniline spectrophotometrically. J Chem Pharm Res. 2011;3:790–796.
   Google Scholar
• Janz JM, Farrens DL. Assessing structural elements that influence Schiff base stability: mutants E113Q and D190N destabilize rhodopsin through different mechanisms. Vision Res. 2003;43(28):2991–3002.
   PubMed Web of Science ®Google Scholar
• Chohan ZH, Hernandes MZ, Sensato FR, et al. Sulfonamide–metal complexes endowed with potent anti-Trypanosoma cruzi activity. J Enzyme Inhib Med Chem. 2014;29(2):230–236.
   PubMed Web of Science ®Google Scholar
• Chohan ZH, Shad HA, Supuran CT. Synthesis, characterization and biological studies of sulfonamide Schiff’s bases and some of their metal derivatives. J Enzyme Inhib Med Chem. 2012;27(1):58–68.
   PubMed Web of Science ®Google Scholar
• Chohan ZH, Shad HA. Sulfonamide‐derived compounds and their transition metal complexes: synthesis, biological evaluation and X‐ray structure of 4‐bromo‐2‐[(E)‐{4‐[(3, 4‐dimethylisoxazol‐5 yl) sulfamoyl] phenyl} iminiomethyl] phenolate. Appl Organomet Chem. 2011;25(8):591–600.
   Web of Science ®Google Scholar
• Chohan ZH, Shad HA. Metal-based new sulfonamides: design, synthesis, antibacterial, antifungal, and cytotoxic properties. J Enzyme Inhib Med Chem. 2012;27(3):403–412.
   PubMed Web of Science ®Google Scholar
• Chohan ZH, Youssoufi MH, Jarrahpour A, et al. Identification of antibacterial and antifungal pharmacophore sites for potent bacteria and fungi inhibition: indolenyl sulfonamide derivatives. Eur J Med Chem. 2010;45(3):1189–1199.
   PubMed Web of Science ®Google Scholar
• Eroglu E. Some QSAR studies for a group of sulfonamide Schiff base as carbonic anhydrase CA II inhibitors. Int J Mol Sci. 2008;9(2):181–197.
   PubMed Web of Science ®Google Scholar
• Ming L-J, Epperson JD. Metal binding and structure–activity relationship of the metalloantibiotic peptide bacitracin. J Inorg Biochem. 2002;91(1):46–58.
   PubMed Web of Science ®Google Scholar
• Lehmann T, Topchiy E. Contributions of NMR to the understanding of the coordination chemistry and DNA Interactions of metallo-bleomycins. Molecules. 2013;18(8):9253–9277.
   PubMed Web of Science ®Google Scholar
• Sakai TT, Riordan JM, Kumar NG, et al. Studies on bleomycin-DNA and bleomycin-iron interactions. J Biomol Struct Dyn. 1983;1(3):809–827.
   PubMed Web of Science ®Google Scholar
• Oppenheimer NJ, Rodriguez LO, Hecht SM. Metal binding to modified bleomycins Zinc and ferrous complexes with an acetylated bleomycin. Biochemistry. 1980;19(17):4096–4103.
   PubMed Web of Science ®Google Scholar
• Murray V, Chen JK, Tanaka MM. The genome-wide DNA sequence specificity of the anti-tumour drug bleomycin in human cells. Mol Biol Rep. 2016;43(7):639–651
   PubMed Web of Science ®Google Scholar
• Hsu C-W, Kuo C-F, Chuang S-M, et al. Elucidation of the DNA-interacting properties and anticancer activity of a Ni (II)-coordinated mithramycin dimer complex. Biometals. 2013;26(1):1–12.
   PubMed Web of Science ®Google Scholar
• Anderberg PI, Harding MM, Lay PA. The effect of metal ions on the electrochemistry of the antitumor antibiotic streptonigrin. J Inorg Biochem. 2004;98(5):720–726.
   PubMed Web of Science ®Google Scholar
• Lahiri S, Takao T, Devi PG, et al. Association of aureolic acid antibiotic, chromomycin A3 with Cu2+ and its negative effect upon DNA binding property of the antibiotic. Biometals. 2012;25(2):435–450.
   PubMed Web of Science ®Google Scholar
• Fiallo M, Garnier-Suillerot A. Metal anthracycline complexes as a new class of anthracycline derivatives Palladium (II)-adriamycin and palladium (II)-daunorubicin complexes: physicochemical characteristics and antitumor activity. Biochemistry. 1986;25(4):924–930.
   PubMed Web of Science ®Google Scholar
• Anand R, Borghi F, Manoli F, et al. Host–guest interactions in Fe (III)-Trimesate MOF nanoparticles loaded with doxorubicin. J Phys Chem B. 2014;118(29):8532–8539.
   PubMed Web of Science ®Google Scholar
• Verma G, Marella A, Shaquiquzzaman M, et al. A review exploring biological activities of hydrazones. J Pharm Bioallied Sci. 2014;6(2):69.
   PubMedGoogle Scholar
• Rollas S, Küçükgüzel SG. Biological activities of hydrazone derivatives. Molecules. 2007;12(8):1910–1939.
   PubMed Web of Science ®Google Scholar
• Kajal A, Bala S, Sharma N, et al. Therapeutic potential of hydrazones as anti-inflammatory agents. Int J Med Chem. 2014;2014:1-11. Available from: https://www.hindawi.com/journals/ijmc/2014/761030/
   Google Scholar
• Kumar P, Narasimhan B. Hydrazides/hydrazones as antimicrobial and anticancer agents in the new millennium. Mini Rev Med Chem. 2013;13(7):971–987.
   PubMed Web of Science ®Google Scholar
• Robinson B. The fischer indole synthesis. Chem Rev. 1963;63(4):373–401.
   Web of Science ®Google Scholar
• Martín‐Zamora E, Ferrete A, Llera JM, et al. Studies on stereoselective [2+ 2] cycloadditions between N, N-dialkylhydrazones and ketenes. Chem Eur J. 2004;10(23):6111–6129.
   PubMed Web of Science ®Google Scholar
• Belskaya NP, Dehaen W, Bakulev VA. Synthesis and properties of hydrazones bearing amide, thioamide and amidine functions. Arkivoc. 2010;1:275–332.
   Google Scholar
• Joshi SD, Kumar D, Dixit SR, et al. Synthesis, characterization and antitubercular activities of novel pyrrolyl hydrazones and their Cu-complexes. Eur J Med Chem. 2016;121:21–39.
   PubMed Web of Science ®Google Scholar
• Mandewale MC, Thorat B, Shelke D, et al. Synthesis and biological evaluation of new hydrazone derivatives of quinoline and their Cu (II) and Zn (II) complexes against Mycobacterium tuberculosis. Bioinorg Chem Appl. 2015;2015:1-14. Available from: https://www.hindawi.com/journals/bca/2015/153015/
   PubMed Web of Science ®Google Scholar
• Ferreira IP, Piló ED, Recio-Despaigne AA, et al. Bismuth (III) complexes with 2-acetylpyridine-and 2-benzoylpyridine-derived hydrazones: antimicrobial and cytotoxic activities and effects on the clonogenic survival of human solid tumor cells. Bioorg Med Chem. 2016;24(13):2988–2998.
   PubMed Web of Science ®Google Scholar
• Ferraz KS, Silva NF, da Silva JG, et al. Investigation on the pharmacological profile of 2, 6-diacetylpyridine bis (benzoylhydrazone) derivatives and their antimony (III) and bismuth (III) complexes. Eur J Med Chem. 2012;53:98–106.
   PubMed Web of Science ®Google Scholar
• Gawande PU, Mandlik P, Aswar A. Synthesis and characterization of Cr (III), Mn (III), Fe (III), VO (IV), Zr (IV) and UO2 (VI) complexes of schiff base derived from isonicotinoyl hydrazone. Indian J Pharm Sci. 2015;77(4):376.
   PubMed Web of Science ®Google Scholar
• Deng J, Gou Y, Chen W, et al. The Cu/ligand stoichiometry effect on the coordination behavior of aroyl hydrazone with copper (II): structure, anticancer activity and anticancer mechanism. Bioorg Med Chem. 2016;24(10):2190–2198.
   PubMed Web of Science ®Google Scholar
• Kajal A, Bala S, Kamboj S, et al. Schiff bases: a versatile pharmacophore. J Catal. 2013;2013:1–14.
   Google Scholar
• Abu-Dief AM, Mohamed IM. A review on versatile applications of transition metal complexes incorporating Schiff bases. Beni-Seuf Univ J Appl Sci. 2015;4(2):119–133.
   Google Scholar
• Kostova I, Saso L. Advances in research of Schiff-base metal complexes as potent antioxidants. Curr Med Chem. 2013;20(36):4609–4632.
   PubMed Web of Science ®Google Scholar
• Harney AS, Lee J, Meade TJ, et al. Targeted schiff base complexes. WO2010111257. 2010.
   Google Scholar
• Harney AS, Lee J, Manus LM, et al. Targeted inhibition of Snail family zinc finger transcription factors by oligonucleotide-Co (III) Schiff base conjugate. Proc Natl Acad Sci. 2009;106(33):13667–13672.
   PubMed Web of Science ®Google Scholar
• Hartwig A. Zinc finger proteins as potential targets for toxic metal ions: differential effects on structure and function. Antioxid Redox Signal. 2001;3(4):625–634.
   PubMed Web of Science ®Google Scholar
• Louie AY, Meade TJ. A cobalt complex that selectively disrupts the structure and function of zinc fingers. Proc Natl Acad Sci. 1998 Jun 9;95(12):6663–6668.
   PubMed Web of Science ®Google Scholar
• Munro OQ, Akerman KJ, Akerman P. Gold complexes for use in the treatment of cancer. US20130090472. 2013.
   Google Scholar
• Florea A-M, Büsselberg D. Cisplatin as an anti-tumor drug: cellular mechanisms of activity, drug resistance and induced side effects. Cancers. 2011;3(1):1351–1371.
   PubMedGoogle Scholar
• Muhammad N, Guo Z. Metal-based anticancer chemotherapeutic agents. Curr Opin Chem Biol. 2014;19:144–153.
   PubMed Web of Science ®Google Scholar
• Hannon MJ. Metal-based anticancer drugs: from a past anchored in platinum chemistry to a post-genomic future of diverse chemistry and biology. Pure Appl Chem. 2007;79(12):2243–2261.
   Web of Science ®Google Scholar
• Finkelstein A, Walz D, Batista V, et al. Auranofin new oral gold compound for treatment of rheumatoid arthritis. Ann Rheum Dis. 1976;35(3):251–257.
   PubMed Web of Science ®Google Scholar
• Milacic V, Fregona D, Dou QP. Gold complexes as prospective metal-based anticancer drugs. Histol Histopathol. 2008;23(1):101–108.
   PubMed Web of Science ®Google Scholar
• Nardon C, Boscutti G, Fregona D. Beyond platinums: gold complexes as anticancer agents. Anticancer Res. 2014;34(1):487–492.
   PubMed Web of Science ®Google Scholar
• Sarkar FH, Dou QP, Padhye S. Novel analogs of curcumin and methods of use. WO2011142795. 2011.
   Google Scholar
• Maheshwari RK, Singh AK, Gaddipati J, et al. Multiple biological activities of curcumin: a short review. Life Sci. 2006;78(18):2081–2087.
   PubMed Web of Science ®Google Scholar
• Anand P, Kunnumakkara AB, Newman RA, et al. Bioavailability of curcumin: problems and promises. Mol Pharm. 2007;4(6):807–818.
   PubMed Web of Science ®Google Scholar
• Leimgruber W, Batcho A, Schenker F. The structure of anthramycin. J Am Chem Soc. 1965;87(24):5793–5795.
   PubMed Web of Science ®Google Scholar
• Howard PW. Pyrrolobenzodiazepines as unsymmetrical dimeric pbd compounds for inclusion in targeted conjugates. WO2013041606. 2013.
   Google Scholar
• Leblond B, Taverne T, Beausoleil E, et al. Substituted isoquinolines and their use as tubulin polymerization inhibitors. WO2011151423. 2011.
   Google Scholar
• Djaballah H, Feldman T, Jiang X, et al. Allosteric reversible pan-caspase inhibitors. . WO2012134822. 2012.
   Google Scholar
• Ekert P, Silke J, Vaux D. Caspase inhibitors. Cell Death Differ. 1999;6(11):1081–1086.
   PubMed Web of Science ®Google Scholar
• Callus B, Vaux D. Caspase inhibitors: viral, cellular and chemical. Cell Death Differ. 2007;14(1):73–78.
   PubMed Web of Science ®Google Scholar
• Keoni CL, Brown TL. Inhibition of apoptosis and efficacy of Pan caspase inhibitor, Q-VD-OPh, in models of human disease. J Cell Death. 2015;8:1.
   PubMedGoogle Scholar
• Robertson GS, Crocker SJ, Nicholson DW, et al. Neuroprotection by the inhibition of apoptosis. Brain Pathol. 2000;10(2):283–292.
   PubMed Web of Science ®Google Scholar
• Rohn TT. The role of caspases in Alzheimer’s disease; potential novel therapeutic opportunities. Apoptosis. 2010;15(11):1403–1409.
   PubMed Web of Science ®Google Scholar
• Bandyopadhyay S. Compounds for photodynamic therapy. WO2012011875. 2012.
   Google Scholar
• Dolmans DE, Fukumura D, Jain RK. Photodynamic therapy for cancer. Nat Rev Cancer. 2003;3(5):380–387.
   PubMed Web of Science ®Google Scholar
• Vrouenraets MB, Visser G, Snow G, et al. Basic principles, applications in oncology and improved selectivity of photodynamic therapy. Anticancer Res. 2002;23(1B):505–522.
   Web of Science ®Google Scholar
• Robertson C, Evans DH, Abrahamse H. Photodynamic therapy (PDT): a short review on cellular mechanisms and cancer research applications for PDT. J Photochem Photobiol B. 2009;96(1):1–8.
   PubMed Web of Science ®Google Scholar
• Zhou HJ, Parlati F, Wustrow D. Methods and compositions for jamm protease inhibition. WO2013123071. 2013.
   Google Scholar
• Turcu FER, Ventii KH, Wilkinson KD. Regulation and cellular roles of ubiquitin-specific deubiquitinating enzymes. Annu Rev Biochem. 2009;78:363–397.
   PubMed Web of Science ®Google Scholar
• Tan Y, Li S. Schiff-base conjugate of n, n-dibutyl-p-phenylenediamine with pyridoxal 5ʹ-phosphate for improved homocysteine assays using pyridoxal 5ʹ-phosphate-dependent enzymes. US20140193801. 2014.
   Google Scholar
• Herrmann W, Pietrzik K, Fowler B, et al. Clinical use and rational management of homocysteine, folic acid, and B vitamins in cardiovascular and thrombotic diseases. Z Kardiol. 2004;93(6):439–453.
   PubMedGoogle Scholar
• Fanapour PC, Yug B, Kochar MS. Hyperhomocysteinemia: an additional cardiovascular risk factor. WMJ. 1999;98(8):51–54.
   PubMedGoogle Scholar
• Kunz K, Petitjean P, Lisri M, et al. Cardiovascular morbidity and endothelial dysfunction in chronic haemodialysis patients: is homocyst (e) ine the missing link? Nephrol Dial Transplant. 1999;14(8):1934–1942.
   PubMed Web of Science ®Google Scholar
• Maron BA, Loscalzo J. The treatment of hyperhomocysteinemia. Annu Rev Med. 2009;60:39–54.
   PubMed Web of Science ®Google Scholar
• Özkan Y, Yardim-Akaydin S, Firat H, et al. Usefulness of homocysteine as a cancer marker: total thiol compounds and folate levels in untreated lung cancer patients. Anticancer Res. 2007;27(2):1185–1189.
   PubMed Web of Science ®Google Scholar
• Domínguez RO, Marschoff ER, Guareschi EM, et al. Homocysteine, vitamin B 12 and folate in Alzheimer’s and vascular dementias: The paradoxical effect of the superimposed type II diabetes mellitus condition. Clin Chim Acta. 2005;359(1):163–170.
   PubMed Web of Science ®Google Scholar
• Pohanka M. Acetylcholinesterase inhibitors: a patent review (2008–present). Expert Opin Ther Pat. 2012;22(8):871–886.
   PubMed Web of Science ®Google Scholar
• Pohanka M. Alzheimer s disease and oxidative stress: a review. Curr Med Chem. 2014;21(3):356–364.
   PubMed Web of Science ®Google Scholar
• Anand P, Singh B. A review on cholinesterase inhibitors for Alzheimer’s disease. Arch Pharmacal Res. 2013;36(4):375–399.
   PubMed Web of Science ®Google Scholar
• Schwarz S, Csuk R, Rauter A. Microwave-assisted synthesis of novel purine nucleosides as selective cholinesterase inhibitors. Org Biomol Chem. 2014;12(15):2446–2456.
   PubMed Web of Science ®Google Scholar
• Gabellieri E, Guba W, Hilpert H, et al. 1,4-oxazepines as bace1 and/or bace2 inhibitors. US20120238548. 2012.
   Google Scholar
• Vassar R. The β-secretase, BACE. J Mol Neurosci. 2001;17(2):157–170.
   PubMed Web of Science ®Google Scholar
• Banner D, Guba W, Hilpert H, et al. 2,5,6,7-tetrahydro-[1,4]oxazepin-3-ylamine or 2,3,6,7-tetrahydro-[1,4]oxazepin-5-ylamine compounds. WO 2011138293. 2011.
   Google Scholar
• Andreini M, Banner D, Guba W, et al. 3-amino-5-phenyl-5,6-dihydro-2h-[1,4]oxazine derivatives. WO2011020806. 2011.
   Google Scholar
• Al-Resayes SI, Warad I, Al-Nuri MA, et al. Heterocyclic schiff’s bases as novel and new antiglycation agents. US20140221429. 2014.
   Google Scholar
• Ali MA, Ismail R, Pandian S, et al. Anti-mycobacterial agents. WO2012057599. 2012.
   Google Scholar
• Owens JR, Salter WB, Simpson KM. Select schiff base compounds for chemical agent detoxification. US20150079304. 2015.
   Google Scholar
• Barentsz J, Takahashi S, Oyen W, et al. Commonly used imaging techniques for diagnosis and staging. J Clin Oncol. 2006 Jul 10;24(20):3234–3244.
   PubMed Web of Science ®Google Scholar
• Yacoub JH, Verma S, Moulton JS, et al. Imaging-guided prostate biopsy: conventional and emerging techniques. Radiographics. 2012;32(3):819–837.
   PubMed Web of Science ®Google Scholar
• Koori H. Near infrared fluorescent imaging agent. US8765961. 2014.
   Google Scholar
• Mowatt G, Brazzelli M, Gemmell H, et al. Systematic review of the prognostic effectiveness of SPECT myocardial perfusion scintigraphy in patients with suspected or known coronary artery disease and following myocardial infarction. Nucl Med Commun. 2005;26(3):217–229.
   PubMed Web of Science ®Google Scholar
• Piwnica-Worms D, Sharma V, Sivapackiam J. Pet/spect agents for applications in biomedical imaging. WO2012109611. 2012.
   Google Scholar
• Narine A, Dickhaut J, Kaiser F, et al. Substituted mesoionic imine compounds for combating animal pests. WO2014033244. 2014.
   Google Scholar
• Bandur NG, Deshmukh P, Dickhaut J, et al. Imine compounds. WO2012042006. 2012.
   Google Scholar
• Anspaugh DD, Bandur NG, Braun FJ, et al. Imine substituted 2, 4 - diaryl - pyrroline derivatives as pesticides. WO 2012042007. (2012.
   Google Scholar
• Körber K, Kaiser F, Pohlman M, et al. Imine compounds for combating invertebrate pests. WO2010072781. 2010.
   Google Scholar
• Kosikowska P, Berlicki Ł. Urease inhibitors as potential drugs for gastric and urinary tract infections: a patent review. Expert Opin Ther Pat. 2011 Jul 1];21(6):945–957.
   PubMed Web of Science ®Google Scholar
• Choudhary MI, Khan A, Khan KM, et al. Schiff bases of thiazoles: a new class of ureases inhibitors. US20150368214. 2015.
   Google Scholar
• Xing M. Schiff-based aldehydic hyaluronic acid-chitosan hydrogel compositions and uses thereof. WO 2014161085. 2014.
   Google Scholar
• Al-Rubeaan KA. Wound dressing comprising of silver chitosan. WO2012143788. 2012.
   Google Scholar